Utrecht Coronary Biobank (UCORBIO)
This trial is active, not recruiting.
|Condition||coronary artery disease|
|Treatment||observational study, no intervention.|
|Start date||October 2011|
|End date||December 2014|
|Trial size||3000 participants|
|Trial identifier||NCT02304744, 11/183|
UCORBIO enrolls patients who undergo coronary angiography (for any indication). The investigators draw blood at the moment of insertion of the procedural arterial catheter.
At the moment of inclusion indication, procedural details, risk factor status, medication use and quality of life (RAND-36 and EuroQoL) is assessed. Patients are then followed-up for the occurrence of major adverse cardiovascular events for 5 years. During the follow-up period patients receive a questionnaire every year to check for hospital admissions. The questionnaires at two and five years of follow-up are enriched with quality of life questionnaires (RAND-36 and EuroQoL).
major adverse cardiovascular events [MACE] (Stroke, myocardial infarction, coronary revascularization, death)
time frame: 5 years
Male or female participants at least 18 years old.
- Coronary angiography
- Age < 18 years.
|Official title||Utrecht Coronary Biobank (UCORBIO)|
Call for more information